Insteon

SmartLabs Announces Biopharma Veteran Brian Taylor as New Interim CEO

Retrieved on: 
Thursday, January 11, 2024

BOSTON, Jan. 11, 2024 /PRNewswire/ -- SmartLabs, Inc. , the leading provider of modular laboratory infrastructure and resourcing solutions, today announced that Brian Taylor has been appointed interim Chief Executive Officer effective January 5th.

Key Points: 
  • BOSTON, Jan. 11, 2024 /PRNewswire/ -- SmartLabs, Inc. , the leading provider of modular laboratory infrastructure and resourcing solutions, today announced that Brian Taylor has been appointed interim Chief Executive Officer effective January 5th.
  • Taylor has been serving as SmartLabs' Executive Vice President of Biopharma Solutions since 2020, and as a 25-year veteran of the pharmaceutical industry, he brings a wealth of experience and an impressive skill set to his new position.
  • "We are thrilled to welcome Brian as the new interim CEO of SmartLabs," said Clayton Freeman, Portfolio Manager at ArrowMark Partners and SmartLabs board member.
  • I look forward to working with our exceptional SmartLabs team as we further develop our solutions offering to answer our customers' unique needs."

iFLYTEK Launches Budapest Joint A.I. Open Platform at World Athletics Championships Budapest 23

Retrieved on: 
Saturday, August 26, 2023

Open Platform this week at the World Athletics Championships (WAC) in Budapest, Hungary.

Key Points: 
  • Open Platform this week at the World Athletics Championships (WAC) in Budapest, Hungary.
  • At the press conference, Director of the iFLYTEK R&D Institute Mingkang Long, said the Joint A.I.
  • Open Platform during the World Athletics Championships Budapest 23. iFLYTEK serves as the official event supplier of the Championships and supplies the WAC Budapest 23 with communication and translation capabilities.
  • By synergizing its capabilities with its partners' technologies, iFLYTEK has provided barrier-free technical services for the WAC Budapest 23.

NSTC Joins Forces with Taiwan Biomedical Start-ups to Rise to the World Stage, Showcasing Innovations at US BIO's Demo Day

Retrieved on: 
Wednesday, June 7, 2023

The event effectively assisted start-up teams in establishing global exposure and promoting cooperation and exchange between Taiwan's biotech industry and the global market.

Key Points: 
  • The event effectively assisted start-up teams in establishing global exposure and promoting cooperation and exchange between Taiwan's biotech industry and the global market.
  • The Demo Day was held in the form of Demo & Pitch, featuring presentations by 20 teams supported by NSTC.
  • Among them, Taipei Veterans General Hospital, China Medical University Hospital and Show Chwan Memorial Hospital are the teams of NSTC's Smart Healthcare Industry-Academia Consortium Project.
  • JelloX Biotech has developed patented 3D pathology tissue processing and imaging technology to develop next-generation pathology detection technology.

Bisnow Announces Premier Two-Day Commercial Real Estate-Focused International Life Sciences & Biotech Conference

Retrieved on: 
Tuesday, April 18, 2023

PHILADELPHIA, April 18, 2023 /PRNewswire/ -- Bisnow , the leading commercial real estate (CRE) news and events platform, is pleased to announce its first International Life Sciences & Biotech Conference , taking place October 11-12, at the Pennsylvania Convention Center in Philadelphia, PA.

Key Points: 
  • PHILADELPHIA, April 18, 2023 /PRNewswire/ -- Bisnow , the leading commercial real estate (CRE) news and events platform, is pleased to announce its first International Life Sciences & Biotech Conference , taking place October 11-12, at the Pennsylvania Convention Center in Philadelphia, PA.
  • The two-day event will bring together industry leaders and innovators to discuss the latest trends and developments in the life sciences sector.
  • "We've been putting on huge life sciences events around the globe for years now with sold-out crowds from London to Boston.
  • "I'm thrilled to announce this one-of-a-kind conference and cannot wait to see the hundreds of executives across real estate and biotech come together in October."

Berkeley Investments Moves Forward to Build New Innovation Cluster in Boston

Retrieved on: 
Monday, March 20, 2023

The expanding Harvard presence in Allston is establishing a new cluster for innovation and research in Greater Boston and reinforcing the strong development link between two existing world-renowned medical research and life science clusters: the Longwood Medical Area (LMA) in Boston and the MIT/Kendall Square powerhouse in Cambridge.

Key Points: 
  • The expanding Harvard presence in Allston is establishing a new cluster for innovation and research in Greater Boston and reinforcing the strong development link between two existing world-renowned medical research and life science clusters: the Longwood Medical Area (LMA) in Boston and the MIT/Kendall Square powerhouse in Cambridge.
  • The two main commercial buildings will include 720,000 square feet of lab, R&D, and office space with exceptional branding opportunities along I-90 in one of the fastest-growing innovation districts in the Northeast.
  • Among the many sustainability features, the Project includes LEED Gold-certified buildings and a 100 percent electrical residential building, resulting in a 90 percent reduction in fossil fuel use.
  • Berkeley intends to break ground on 176 Lincoln in 2024 with a completion date in 2028.

SmartLabs Announces Launch of its Most Advanced Managed Research Center

Retrieved on: 
Wednesday, March 1, 2023

SmartLabs , a company reinventing how therapies and medical devices are developed and brought to market by building the most advanced labs in the world, announced the launch of a new research, development, office, and related production center opening in East Cambridge in late 2024.

Key Points: 
  • SmartLabs , a company reinventing how therapies and medical devices are developed and brought to market by building the most advanced labs in the world, announced the launch of a new research, development, office, and related production center opening in East Cambridge in late 2024.
  • Since its debut in 2015, SmartLabs has hosted more than 17 percent of all venture-funded life science projects in the region; the new East Cambridge site will expand SmartLabs’ Greater Boston footprint by 75 percent.
  • Scott Burns, Real Estate Asset Manager, UBS Asset Management, says, “SmartLabs is a preeminent operator of managed life science environments.
  • We are thrilled that SmartLabs will create its newest Boston area lab/office facility in East Cambridge, at the heart of CambridgeSide.

JLL arranges major capitalization for Gattuso Development's new Philadelphia life sciences project

Retrieved on: 
Monday, December 19, 2022

PHILADELPHIA, Dec. 19, 2022 /PRNewswire/ -- JLL's Capital Markets group announced today that it has arranged a $290 million construction loan that will allow project partners Gattuso Development Partners and Vigilant Holdings of New York to build a state-of-the-art research facility at 3201 Cuthbert Street, an 11-story life sciences development in the heart of Philadelphia's University City submarket.

Key Points: 
  • Working on behalf of Gattuso and Vigilant, JLL secured the loan through Corebridge Financial, as well as an additional equity commitment through The Baupost Group.
  • This will mark SmartLab's seventh location and first commitment to a market outside of San Francisco or Boston, demonstrating the strength of the Philadelphia life sciences market, which was ranked fifth in the nation in JLL's 2022 Life Sciences Lab Real Estate Outlook .
  • "We appreciate the chance to work with the great team at JLL to complete the capital stack for this important project," said John Gattuso, Gattuso's President and co-founder.
  • "We believe the project validates Philadelphia's emergence as a global hub for life sciences research, and we are excited to begin construction."

Door and Window Automation Market worth $23.6 billion by 2027 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Thursday, September 1, 2022

CHICAGO, Sept. 1, 2022 /PRNewswire/ -- Door And Window Automation Market size is estimated to be USD 18.3 billion in 2022 and is projected to reach USD 23.6 billion by 2027, at a CAGR of 5.2%,according to a new report by MarketsandMarkets.

Key Points: 
  • CHICAGO, Sept. 1, 2022 /PRNewswire/ -- Door And Window Automation Market size is estimated to be USD 18.3 billion in 2022 and is projected to reach USD 23.6 billion by 2027, at a CAGR of 5.2%,according to a new report by MarketsandMarkets.
  • The increasing demand for automated doors in various industries and rising infrastructure development projects worldwide are responsible for the growth of door and window automation market.
  • North America is one of the leading regions in the door and window automation market.
  • Countries such as the US, Canada, and Mexico play a major role in the North American door and window automation market.

Door and Window Automation Market worth $23.6 billion by 2027 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Thursday, September 1, 2022

CHICAGO, Sept. 1, 2022 /PRNewswire/ -- Door And Window Automation Market size is estimated to be USD 18.3 billion in 2022 and is projected to reach USD 23.6 billion by 2027, at a CAGR of 5.2%,according to a new report by MarketsandMarkets.

Key Points: 
  • CHICAGO, Sept. 1, 2022 /PRNewswire/ -- Door And Window Automation Market size is estimated to be USD 18.3 billion in 2022 and is projected to reach USD 23.6 billion by 2027, at a CAGR of 5.2%,according to a new report by MarketsandMarkets.
  • The increasing demand for automated doors in various industries and rising infrastructure development projects worldwide are responsible for the growth of door and window automation market.
  • North America is one of the leading regions in the door and window automation market.
  • Countries such as the US, Canada, and Mexico play a major role in the North American door and window automation market.

SmartLabs Announces Plans to Expand High-Performance Laboratory Facilities in Philadelphia

Retrieved on: 
Monday, August 1, 2022

Philadelphia has a trailblazing community of companies advancing cell & gene therapies, and SmartLabs new facilities will improve their scientific outcomes, accelerating time from discovery to commercialization.

Key Points: 
  • Philadelphia has a trailblazing community of companies advancing cell & gene therapies, and SmartLabs new facilities will improve their scientific outcomes, accelerating time from discovery to commercialization.
  • By licensing SmartLabs state-of-the-art laboratory facilities rather than investing substantial time and money in building new space, biopharma companies can focus on their science and get new treatments to patients faster.
  • We look forward to SmartLabs presence in Philadelphia R&D and to the scientific advances that will come out of their facilities.
  • SmartLabs provides in-house design, architecture, and construction management, as well as full-service lab operations and facilities management and a suite of shared amenities.